| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000269082.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037459872 |
Sensitive |
| ENSG00000269082.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047392621 |
Sensitive |
